Tokyo Tape
Sign in
← Wakamoto Pharmaceutical

Half-year report · Q2

4512.TEDINET S100UQE7
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥3.8bn2024-04-01 → 2024-09-30StandaloneNet sales
Revenue¥7.7bn2023-04-01 → 2024-03-31StandaloneNet sales (5-year summary)
Revenue¥3.6bn2023-04-01 → 2023-09-30StandaloneNet sales
Operating income−¥277m2024-04-01 → 2024-09-30StandaloneOperating income
Operating income−¥328m2023-04-01 → 2023-09-30StandaloneOperating income
Ordinary income−¥256m2024-04-01 → 2024-09-30StandaloneOrdinary income
Ordinary income−¥162m2023-04-01 → 2024-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥320m2023-04-01 → 2023-09-30StandaloneOrdinary income
Profit before tax−¥260m2024-04-01 → 2024-09-30StandaloneIncome before income taxes
Profit before tax−¥170m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Net income−¥142m2024-04-01 → 2024-09-30StandaloneProfit loss
Net income¥109m2023-04-01 → 2024-03-31StandaloneNet income loss (5-year summary)
Net income−¥223m2023-04-01 → 2023-09-30StandaloneProfit loss
Total assets¥15.3bnat 2024-09-30StandaloneAssets
Total assets¥15.4bnat 2024-03-31StandaloneAssets
Total assets¥15.8bnat 2023-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.3bnat 2024-09-30StandaloneLiabilities
Total liabilities¥3.4bnat 2024-03-31StandaloneLiabilities
Net assets / equity¥11.9bnat 2024-09-30StandaloneNet assets
Net assets / equity¥12.0bnat 2024-03-31StandaloneNet assets
Net assets / equity¥12.0bnat 2023-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥3.6bnat 2024-09-30StandaloneCash and deposits
Cash and deposits¥3.7bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥3.6bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.7bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥4.0bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.9bnat 2023-03-31dStandaloneCash and cash equivalents
Operating cash flow¥283m2024-04-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥107m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥109m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥225m2024-04-01 → 2024-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥78m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥104m2024-04-01 → 2024-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥105m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥104m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-4.082024-04-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥3.132023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.422023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥32023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Equity ratio78.3%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.0%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.1%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued34,838,000at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued34,838,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued34,838,000at 2023-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.6bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.6bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30−¥644m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥905m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥905m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥106m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.3bn
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.3bn
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥230m
—segment totalrevenue2024-04-01 → 2024-09-30¥3.8bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥3.8bn
—segment totalsegment profit2024-04-01 → 2024-09-30−¥277m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥3.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥3.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30−¥277m
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.6bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.6bn
jpcrp040300-q2r_E00928-000Ethical Products Business Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30−¥475m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥832m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥832m
jpcrp040300-q2r_E00928-000Global Sales Development Business Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥23m
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.1bn
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.1bn
jpcrp040300-q2r_E00928-000Otc Products Business Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥96m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.6bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.6bn
—segment totalsegment profit2023-04-01 → 2023-09-30−¥328m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30−¥328m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 523
ItemContextValueUnit
Retained earningsCurrentQuarterInstant_NonConsolidatedMember4465469000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-36391000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-36432000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember10746626000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember10500749000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember1279447000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember1445766000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember1279447000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember1445766000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember12026073000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember11946516000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember15421054000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember15256746000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember3618388000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember3811000000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember2019241000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember2042910000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember1599146000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember1768089000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember1927525000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember2044771000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-328378000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-276681000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember15000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember226000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember30064000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember26028000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember7623000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember6204000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember37703000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember32459000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember239000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember411000JPY
Loss on retirement of noncurrent assets noePrior1YTDDuration_NonConsolidatedMember8605000JPY
Loss on retirement of noncurrent assets noeCurrentYTDDuration_NonConsolidatedMember216000JPY
Contribution noePrior1YTDDuration_NonConsolidatedMember9819000JPY
Contribution noeCurrentYTDDuration_NonConsolidatedMember10979000JPY
Loss on insurance cancellation noePrior1YTDDuration_NonConsolidatedMember10001000JPY
Loss on insurance cancellation noeCurrentYTDDuration_NonConsolidatedMember－JPY
Other noePrior1YTDDuration_NonConsolidatedMember499000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember523000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember29164000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember12131000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-319840000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-256353000JPY
Gain on sales of investment securities eiPrior1YTDDuration_NonConsolidatedMember175097000JPY
Gain on sales of investment securities eiCurrentYTDDuration_NonConsolidatedMember－JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember175097000JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember5428000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-03-31pass rounding
balance sheet identitynon_consolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass